Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones GSL Q1 2026 Earnings EPS Surpasses Estimates Despite Broader Market Headwinds INGR Q1 2026 Earnings EPS Misses Estimates Amid Cost Pressures Stock Holds Steady UCL Q1 2026 Earnings Narrower Loss Surprises Analysts as Shares Dip SURG Q4 2025 Earnings Massive EPS Miss Surprises Market BMO Q1 2026 Earnings Profit Beat Drives Modest Share Gains